InspireMD Q1 EPS $(0.22) Misses $(0.20) Estimate, Sales $1.53M Beat $1.45M Estimate
Author: Benzinga Newsdesk | May 09, 2025 06:02am
InspireMD (NASDAQ:
NSPR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10 percent. This is a 4.76 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.53 million which beat the analyst consensus estimate of $1.45 million by 5.45 percent. This is a 1.19 percent increase over sales of $1.51 million the same period last year.
Posted In: NSPR